Drug therapy for myelodysplastic syndrome: Building evidence for action

Ayalew Tefferi, Louis Letendre

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1650-1652
Number of pages3
JournalCancer
Volume106
Issue number8
DOIs
StatePublished - May 15 2006

Fingerprint

Antineoplastic Antimetabolites
DNA Modification Methylases
Azacitidine
Myelodysplastic Syndromes
DNA Methylation
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Drug therapy for myelodysplastic syndrome : Building evidence for action. / Tefferi, Ayalew; Letendre, Louis.

In: Cancer, Vol. 106, No. 8, 15.05.2006, p. 1650-1652.

Research output: Contribution to journalArticle

Tefferi, Ayalew ; Letendre, Louis. / Drug therapy for myelodysplastic syndrome : Building evidence for action. In: Cancer. 2006 ; Vol. 106, No. 8. pp. 1650-1652.
@article{6eab336f95464d17a85ad1aa0557e126,
title = "Drug therapy for myelodysplastic syndrome: Building evidence for action",
author = "Ayalew Tefferi and Louis Letendre",
year = "2006",
month = "5",
day = "15",
doi = "10.1002/cncr.21793",
language = "English (US)",
volume = "106",
pages = "1650--1652",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Drug therapy for myelodysplastic syndrome

T2 - Building evidence for action

AU - Tefferi, Ayalew

AU - Letendre, Louis

PY - 2006/5/15

Y1 - 2006/5/15

UR - http://www.scopus.com/inward/record.url?scp=33646048349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646048349&partnerID=8YFLogxK

U2 - 10.1002/cncr.21793

DO - 10.1002/cncr.21793

M3 - Article

C2 - 16532501

AN - SCOPUS:33646048349

VL - 106

SP - 1650

EP - 1652

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 8

ER -